Intérêt de l’association TEP-FDG et biopsie percutanée dans le diagnostic des MPNST sur NF1
Mehdi Brahmi(Centre Léon Bérard), P. Combemale(Centre Léon Bérard), S. Pinson(Hôpital Edouard Herriot), Philippe Thiesse(Institut Gustave Roussy), Anne‐Valérie Decouvelaere(Centre Léon Bérard), Thomas Mognetti(Centre de Recherche en Cancérologie de Lyon), Dominique Ranchère‐Vince(Centre Léon Bérard)
Cited by 0
Related Papers
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
|The Lancet Oncology|2015|432
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
|Nature Genetics|2015|375
Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study
|British Journal of Dermatology|2019|197
Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement
|Cytogenetics and Cell Genetics|2008|194
Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study
|Journal of the European Academy of Dermatology and Venereology|2017|192